Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas C Issa

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Blood|March 2, 2018
Risk of hepatitis B virus reactivation in patients treated with ibrutinibSarah P Hammond, Kaiwen Chen, Alisha Pandit, et al.
Diagnostic Microbiology and Infectious Disease|February 6, 2004
In vitro activity of BAL9141 against clinical isolates of gram-negative bacteriaNicolas C Issa, Mark S Rouse, Kerryl E Piper, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2011
Candida albicans cervical lymphadenitis in patients who have acute myeloid leukemiaMarcella M Alsan, Nicolas C Issa, Sarah P Hammond, et al.
Leukemia & Lymphoma|July 25, 2018
Isavuconazole for the treatment of invasive fungal disease in patients receiving ibrutinibKaelyn C Cummins, Matthew P Cheng, David W Kubiak, et al.
Journal of Virology|October 3, 2008
Absence of replication of porcine endogenous retrovirus and porcine lymphotropic herpesvirus type 1 with prolonged pig cell microchimerism after pig-to-baboon xenotransplantationNicolas C Issa, Robert A Wilkinson, Adam Griesemer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 26, 2013
Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipientsNicolas C Issa, Francisco M Marty, Houry Leblebjian, et al.
Open Forum Infectious Diseases|May 25, 2026
Invasive Fusariosis: A Retrospective Case Series Evaluating In Vitro Minimum Inhibitory Concentrations and Clinical ResponseVictor Kovac, Sarah P Hammond, Nicolas C Issa, et al.
Bone Marrow Transplantation|February 11, 2018
Safety of live-attenuated measles-mumps-rubella and herpes zoster vaccination in multiple myeloma patients on maintenance lenalidomide or bortezomib after autologous hematopoietic cell transplantationAlisha Pandit, Houry Leblebjian, Sarah P Hammond, et al.
Blood Advances|March 12, 2021
Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantationEmily Baumrin, Natalie E Izaguirre, Bruce Bausk, et al.
Transplantation and Cellular Therapy|February 3, 2023
Impact of Donor and Recipient SARS-CoV-2 Vaccination or Infection on Immunity after Hematopoietic Cell TransplantationAmy C Sherman, Chi-An Cheng, Zoe Swank, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Blood|March 2, 2018
Risk of hepatitis B virus reactivation in patients treated with ibrutinibSarah P Hammond, Kaiwen Chen, Alisha Pandit, et al.
Diagnostic Microbiology and Infectious Disease|February 6, 2004
In vitro activity of BAL9141 against clinical isolates of gram-negative bacteriaNicolas C Issa, Mark S Rouse, Kerryl E Piper, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 6, 2011
Candida albicans cervical lymphadenitis in patients who have acute myeloid leukemiaMarcella M Alsan, Nicolas C Issa, Sarah P Hammond, et al.
Leukemia & Lymphoma|July 25, 2018
Isavuconazole for the treatment of invasive fungal disease in patients receiving ibrutinibKaelyn C Cummins, Matthew P Cheng, David W Kubiak, et al.
Journal of Virology|October 3, 2008
Absence of replication of porcine endogenous retrovirus and porcine lymphotropic herpesvirus type 1 with prolonged pig cell microchimerism after pig-to-baboon xenotransplantationNicolas C Issa, Robert A Wilkinson, Adam Griesemer, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 26, 2013
Live attenuated varicella-zoster vaccine in hematopoietic stem cell transplantation recipientsNicolas C Issa, Francisco M Marty, Houry Leblebjian, et al.
Open Forum Infectious Diseases|May 25, 2026
Invasive Fusariosis: A Retrospective Case Series Evaluating In Vitro Minimum Inhibitory Concentrations and Clinical ResponseVictor Kovac, Sarah P Hammond, Nicolas C Issa, et al.
Bone Marrow Transplantation|February 11, 2018
Safety of live-attenuated measles-mumps-rubella and herpes zoster vaccination in multiple myeloma patients on maintenance lenalidomide or bortezomib after autologous hematopoietic cell transplantationAlisha Pandit, Houry Leblebjian, Sarah P Hammond, et al.
Blood Advances|March 12, 2021
Safety and reactogenicity of the recombinant zoster vaccine after allogeneic hematopoietic cell transplantationEmily Baumrin, Natalie E Izaguirre, Bruce Bausk, et al.
Transplantation and Cellular Therapy|February 3, 2023
Impact of Donor and Recipient SARS-CoV-2 Vaccination or Infection on Immunity after Hematopoietic Cell TransplantationAmy C Sherman, Chi-An Cheng, Zoe Swank, et al.
Pageof 5